Literature DB >> 9864217

Gamma interferon augments macrophage activation by lipopolysaccharide by two distinct mechanisms, at the signal transduction level and via an autocrine mechanism involving tumor necrosis factor alpha and interleukin-1.

T K Held1, X Weihua, L Yuan, D V Kalvakolanu, A S Cross.   

Abstract

When given in the presence of gamma interferon (IFN-gamma), otherwise nontoxic doses of lipopolysaccharide (LPS or endotoxin) become highly lethal for mice. The mechanisms of this synergistic toxicity are not known. We considered the possibility that an interaction between the LPS-induced NF-kappaB and IFN-gamma-induced JAK-STAT pathways at the pretranscriptional level may enhance the LPS-induced signals. To test this hypothesis, we incubated murine macrophage RAW 264.7 cells with IFN-gamma for 2 h before addition of different doses of LPS. Consistent with the synergistic induction of inducible nitric oxide synthase mRNA and nitric oxide production by a combination of LPS and IFN-gamma, IFN-gamma strongly augmented LPS-induced NF-kappaB activation and accelerated the binding of NF-kappaB to DNA to as early as 5 min. In agreement with this, IFN-gamma pretreatment promoted rapid degradation of IkappaB-alpha but not that of IkappaB-beta. Inhibition of protein synthesis during IFN-gamma treatment suppressed LPS-initiated NF-kappaB binding. A rapidly induced protein appeared to be involved in IFN-gamma priming. Preincubation of cells with antibodies to tumor necrosis factor alpha or the interleukin-1 receptor partially reduced the priming effect of IFN-gamma. In a complementary manner, LPS enhanced the activation of signal-transducing activator of transcription 1 by IFN-gamma. These data suggest novel mechanisms for the synergy between IFN-gamma and LPS by which they cross-regulate the signal-transducing molecules. Through this mechanism, IFN-gamma may transform a given dose of LPS into a lethal stimulus capable of causing sepsis. It may also serve a beneficial purpose by enabling the host to respond quickly to relatively low doses of LPS and thereby activating antibacterial defenses.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9864217      PMCID: PMC96298     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  41 in total

Review 1.  Function and activation of NF-kappa B in the immune system.

Authors:  P A Baeuerle; T Henkel
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

2.  The genomic structure of the murine ICSBP gene reveals the presence of the gamma interferon-responsive element, to which an ISGF3 alpha subunit (or similar) molecule binds.

Authors:  Y Kanno; C A Kozak; C Schindler; P H Driggers; D L Ennist; S L Gleason; J E Darnell; K Ozato
Journal:  Mol Cell Biol       Date:  1993-07       Impact factor: 4.272

3.  Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase.

Authors:  Q W Xie; Y Kashiwabara; C Nathan
Journal:  J Biol Chem       Date:  1994-02-18       Impact factor: 5.157

Review 4.  Nuclear factor kappa B, a mediator of lipopolysaccharide effects.

Authors:  J M Müller; H W Ziegler-Heitbrock; P A Baeuerle
Journal:  Immunobiology       Date:  1993-04       Impact factor: 3.144

5.  Interferon-gamma and polyunsaturated fatty acids increase the binding of lipopolysaccharide to macrophages.

Authors:  H Darmani; J Parton; J L Harwood; S K Jackson
Journal:  Int J Exp Pathol       Date:  1994-10       Impact factor: 1.925

6.  IFN-gamma and lipopolysaccharide differentially modulate expression of tumor necrosis factor receptor mRNA in murine peritoneal macrophages.

Authors:  C S Tannenbaum; J A Major; T A Hamilton
Journal:  J Immunol       Date:  1993-12-15       Impact factor: 5.422

7.  Double-stranded RNA-dependent protein kinase activates transcription factor NF-kappa B by phosphorylating I kappa B.

Authors:  A Kumar; J Haque; J Lacoste; J Hiscott; B R Williams
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-05       Impact factor: 11.205

8.  Expression of the nitric oxide synthase gene in mouse macrophages activated for tumor cell killing. Molecular basis for the synergy between interferon-gamma and lipopolysaccharide.

Authors:  R B Lorsbach; W J Murphy; C J Lowenstein; S H Snyder; S W Russell
Journal:  J Biol Chem       Date:  1993-01-25       Impact factor: 5.157

9.  Mice that lack the interferon-gamma receptor have profoundly altered responses to infection with Bacillus Calmette-Guérin and subsequent challenge with lipopolysaccharide.

Authors:  R Kamijo; J Le; D Shapiro; E A Havell; S Huang; M Aguet; M Bosland; J Vilcek
Journal:  J Exp Med       Date:  1993-10-01       Impact factor: 14.307

10.  Hyaluronan fragments activate an NF-kappa B/I-kappa B alpha autoregulatory loop in murine macrophages.

Authors:  P W Noble; C M McKee; M Cowman; H S Shin
Journal:  J Exp Med       Date:  1996-05-01       Impact factor: 14.307

View more
  49 in total

1.  Donor variability among anti-inflammatory pre-activated mesenchymal stromal cells.

Authors:  Andrea Gray; Rene S Schloss; Martin Yarmush
Journal:  Technology (Singap World Sci)       Date:  2016-09

2.  Evaluation of macrophage plasticity in brown and white adipose tissue.

Authors:  M Teresa Ortega; Linglin Xie; Silvia Mora; Stephen K Chapes
Journal:  Cell Immunol       Date:  2011-06-23       Impact factor: 4.868

3.  Activation of mitogen-activated protein kinases by 5,6-dimethylxanthenone-4-acetic acid (DMXAA) plays an important role in macrophage stimulation.

Authors:  Jing Sun; Liang-Chuan S Wang; Zvi G Fridlender; Veena Kapoor; Guanjun Cheng; Lai-Ming Ching; Steven M Albelda
Journal:  Biochem Pharmacol       Date:  2011-07-26       Impact factor: 5.858

Review 4.  Macrophage phenotype in response to ECM bioscaffolds.

Authors:  Luai Huleihel; Jenna L Dziki; Joseph G Bartolacci; Theresa Rausch; Michelle E Scarritt; Madeline C Cramer; Tatiana Vorobyov; Samuel T LoPresti; Ilea T Swineheart; Lisa J White; Bryan N Brown; Stephen F Badylak
Journal:  Semin Immunol       Date:  2017-07-21       Impact factor: 11.130

Review 5.  Pancreatic islet inflammation: an emerging role for chemokines.

Authors:  J Jason Collier; Tim E Sparer; Michael D Karlstad; Susan J Burke
Journal:  J Mol Endocrinol       Date:  2017-04-18       Impact factor: 5.098

6.  Natural History and Pathogenesis of Wild-Type Marburg Virus Infection in STAT2 Knockout Hamsters.

Authors:  Colm Atkins; Jinxin Miao; Birte Kalveram; Terry Juelich; Jennifer K Smith; David Perez; Lihong Zhang; Jonna L B Westover; Arnaud J Van Wettere; Brian B Gowen; Zhongde Wang; Alexander N Freiberg
Journal:  J Infect Dis       Date:  2018-11-22       Impact factor: 5.226

7.  Oxidized phospholipid, 1-palmitoyl-2-(9'-oxo-nonanoyl)-glycerophosphocholine (PON-GPC), produced in the lung due to cigarette smoking, impairs immune function in macrophages.

Authors:  Tomomi Kimura; Yoko Shibata; Keiko Yamauchi; Akira Igarashi; Sumito Inoue; Shuichi Abe; Kazuhiro Fujita; Yoichi Uosaki; Isao Kubota
Journal:  Lung       Date:  2011-10-11       Impact factor: 2.584

8.  Gamma interferon and lipopolysaccharide interact at the level of transcription to induce tumor necrosis factor alpha expression.

Authors:  J Y Lee; K E Sullivan
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

9.  Haptoglobin dampens endotoxin-induced inflammatory effects both in vitro and in vivo.

Authors:  Mohamed S Arredouani; Ahmad Kasran; Jeroen A Vanoirbeek; Frank G Berger; Heinz Baumann; Jan L Ceuppens
Journal:  Immunology       Date:  2005-02       Impact factor: 7.397

10.  Induction of antimicrobial pathways during early-phase immune response to Salmonella spp. in murine macrophages: gamma interferon (IFN-gamma) and upregulation of IFN-gamma receptor alpha expression are required for NADPH phagocytic oxidase gp91-stimulated oxidative burst and control of virulent Salmonella spp.

Authors:  N Foster; S D Hulme; P A Barrow
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.